Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI

for the Alzheimer’s Disease Neuroimaging Initiative

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

There is substantial biological heterogeneity among older adults with amnestic mild cognitive impairment (aMCI). We hypothesized that this heterogeneity can be detected solely based on volumetric MRI measures, which potentially have clinical implications and can improve our ability to predict clinical outcomes. We used latent class analysis (LCA) to identify subgroups among persons with aMCI (n = 696) enrolled in the Alzheimer’s Disease Neuroimaging Initiative (ADNI), based on baseline volumetric MRI measures. We used volumetric measures of 10 different brain regions. The subgroups were validated with respect to demographics, cognitive performance, and other AD biomarkers. The subgroups were compared with each other and with normal and Alzheimer’s disease (AD) groups with respect to baseline cognitive function and longitudinal rate of conversion. Four aMCI subgroups emerged with distinct MRI patterns: The first subgroup (n = 404), most similar to normal controls in volumetric characteristics and cognitive function, had the lowest incidence of AD. The second subgroup (n = 230) had the most similar MRI profile to early AD, along with poor performance in memory and executive function domains. The third subgroup (n = 36) had the highest global atrophy, very small hippocampus and worst overall cognitive performance. The fourth subgroup (n = 26) had the least amount of atrophy, however still had poor cognitive function specifically in in the executive function domain. Individuals with aMCI who were clinically categorized within one group other showed substantial heterogeneity based on MRI volumetric measures.

Original languageEnglish (US)
JournalBrain Imaging and Behavior
DOIs
StatePublished - Jan 1 2019

Fingerprint

Neuroimaging
Alzheimer Disease
Cognition
Executive Function
Atrophy
Aptitude
Hippocampus
Biomarkers
Demography
Cognitive Dysfunction
Incidence
Brain

Keywords

  • Alzheimer’s disease
  • Amnestic MCI
  • Cognitive function
  • Latent class analysis
  • Volumetric MRI

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Neurology
  • Cognitive Neuroscience
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health
  • Behavioral Neuroscience

Cite this

Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI. / for the Alzheimer’s Disease Neuroimaging Initiative.

In: Brain Imaging and Behavior, 01.01.2019.

Research output: Contribution to journalArticle

@article{722d758af75849eab02f075add2625f7,
title = "Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI",
abstract = "There is substantial biological heterogeneity among older adults with amnestic mild cognitive impairment (aMCI). We hypothesized that this heterogeneity can be detected solely based on volumetric MRI measures, which potentially have clinical implications and can improve our ability to predict clinical outcomes. We used latent class analysis (LCA) to identify subgroups among persons with aMCI (n = 696) enrolled in the Alzheimer’s Disease Neuroimaging Initiative (ADNI), based on baseline volumetric MRI measures. We used volumetric measures of 10 different brain regions. The subgroups were validated with respect to demographics, cognitive performance, and other AD biomarkers. The subgroups were compared with each other and with normal and Alzheimer’s disease (AD) groups with respect to baseline cognitive function and longitudinal rate of conversion. Four aMCI subgroups emerged with distinct MRI patterns: The first subgroup (n = 404), most similar to normal controls in volumetric characteristics and cognitive function, had the lowest incidence of AD. The second subgroup (n = 230) had the most similar MRI profile to early AD, along with poor performance in memory and executive function domains. The third subgroup (n = 36) had the highest global atrophy, very small hippocampus and worst overall cognitive performance. The fourth subgroup (n = 26) had the least amount of atrophy, however still had poor cognitive function specifically in in the executive function domain. Individuals with aMCI who were clinically categorized within one group other showed substantial heterogeneity based on MRI volumetric measures.",
keywords = "Alzheimer’s disease, Amnestic MCI, Cognitive function, Latent class analysis, Volumetric MRI",
author = "{for the Alzheimer’s Disease Neuroimaging Initiative} and Ali Ezzati and Zammit, {Andrea R.} and Christian Habeck and Hall, {Charles B.} and Lipton, {Richard B.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s11682-019-00115-6",
language = "English (US)",
journal = "Brain Imaging and Behavior",
issn = "1931-7557",
publisher = "Springer New York",

}

TY - JOUR

T1 - Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI

AU - for the Alzheimer’s Disease Neuroimaging Initiative

AU - Ezzati, Ali

AU - Zammit, Andrea R.

AU - Habeck, Christian

AU - Hall, Charles B.

AU - Lipton, Richard B.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - There is substantial biological heterogeneity among older adults with amnestic mild cognitive impairment (aMCI). We hypothesized that this heterogeneity can be detected solely based on volumetric MRI measures, which potentially have clinical implications and can improve our ability to predict clinical outcomes. We used latent class analysis (LCA) to identify subgroups among persons with aMCI (n = 696) enrolled in the Alzheimer’s Disease Neuroimaging Initiative (ADNI), based on baseline volumetric MRI measures. We used volumetric measures of 10 different brain regions. The subgroups were validated with respect to demographics, cognitive performance, and other AD biomarkers. The subgroups were compared with each other and with normal and Alzheimer’s disease (AD) groups with respect to baseline cognitive function and longitudinal rate of conversion. Four aMCI subgroups emerged with distinct MRI patterns: The first subgroup (n = 404), most similar to normal controls in volumetric characteristics and cognitive function, had the lowest incidence of AD. The second subgroup (n = 230) had the most similar MRI profile to early AD, along with poor performance in memory and executive function domains. The third subgroup (n = 36) had the highest global atrophy, very small hippocampus and worst overall cognitive performance. The fourth subgroup (n = 26) had the least amount of atrophy, however still had poor cognitive function specifically in in the executive function domain. Individuals with aMCI who were clinically categorized within one group other showed substantial heterogeneity based on MRI volumetric measures.

AB - There is substantial biological heterogeneity among older adults with amnestic mild cognitive impairment (aMCI). We hypothesized that this heterogeneity can be detected solely based on volumetric MRI measures, which potentially have clinical implications and can improve our ability to predict clinical outcomes. We used latent class analysis (LCA) to identify subgroups among persons with aMCI (n = 696) enrolled in the Alzheimer’s Disease Neuroimaging Initiative (ADNI), based on baseline volumetric MRI measures. We used volumetric measures of 10 different brain regions. The subgroups were validated with respect to demographics, cognitive performance, and other AD biomarkers. The subgroups were compared with each other and with normal and Alzheimer’s disease (AD) groups with respect to baseline cognitive function and longitudinal rate of conversion. Four aMCI subgroups emerged with distinct MRI patterns: The first subgroup (n = 404), most similar to normal controls in volumetric characteristics and cognitive function, had the lowest incidence of AD. The second subgroup (n = 230) had the most similar MRI profile to early AD, along with poor performance in memory and executive function domains. The third subgroup (n = 36) had the highest global atrophy, very small hippocampus and worst overall cognitive performance. The fourth subgroup (n = 26) had the least amount of atrophy, however still had poor cognitive function specifically in in the executive function domain. Individuals with aMCI who were clinically categorized within one group other showed substantial heterogeneity based on MRI volumetric measures.

KW - Alzheimer’s disease

KW - Amnestic MCI

KW - Cognitive function

KW - Latent class analysis

KW - Volumetric MRI

UR - http://www.scopus.com/inward/record.url?scp=85066062055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066062055&partnerID=8YFLogxK

U2 - 10.1007/s11682-019-00115-6

DO - 10.1007/s11682-019-00115-6

M3 - Article

AN - SCOPUS:85066062055

JO - Brain Imaging and Behavior

JF - Brain Imaging and Behavior

SN - 1931-7557

ER -